Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SABSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
NA
vs NA
Q4.22
N/A
-0.18
vs NA
Q1.23
N/A
-0.15
vs NA
Q2.23
N/A
-0.14
vs NA
Q3.23
N/A
-0.10
vs NA
Q4.23
N/A
NA
vs -0.18
Q1.24
N/A
NA
vs -0.15
Q2.24
N/A
NA
vs -0.14
Q3.24
N/A
NA
vs -0.10
Q4.24
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
-96%
2.2M vs 60.9M
Q1.23
-100%
NA vs 11.8M
Q2.23
-99%
85.5K vs 6.4M
Q3.23
-65%
1.3M vs 3.6M
Q4.23
-86%
305K vs 2.2M
Q1.24
NA
944.6K vs NA
Q2.24
+208%
263.1K vs 85.5K
Q3.24
-100%
NA vs 1.3M
Q4.24
-62%
114.7K vs 305K
Q1.25
-87%
125K vs 944.6K
Return on Equity
QoQ
Q1.23
-30%
-0.30
vs -0.25
Q2.23
-35%
-0.35
vs -0.30
Q3.23
-33%
-0.33
vs -0.35
Q4.23
-40%
-0.40
vs -0.33
Q1.24
-10%
-0.10
vs -0.40
Q2.24
-16%
-0.16
vs -0.10
Q3.24
-28%
-0.28
vs -0.16
Q4.24
-44%
-0.44
vs -0.28
Institutionnal Ownership
QoQ
Q1.23
14
14
vs 12
17%
Q2.23
11
11
vs 14
-21%
Q3.23
10
10
vs 11
-9%
Q4.23
11
11
vs 10
10%
Q1.24
12
12
vs 11
9%
Q2.24
12
12
vs 12
NA
Q3.24
10
10
vs 12
-17%
Q4.24
10
10
vs 10
NA
Forecast
249%2025-Revenue
98%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.
NASDAQ
-0.00Â ( -7.63%)
Relative Strenght
4
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
0%Relative Strength
SABSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SABSW compares to sector?